A TALK on Retinopathy of Prematurity (ROP) mainly for pediatricians
THE POWERPOINT presentation describes the important diseaee ofROP KEEPING in view teh responsibilities of neonatologists and pediatricians.
Which babies are to be screened and when should they be referred for ROP screening are described.
It describes the criteria for screening for ROP, screening regimen, when to treat what are the complications, different methods of treatment an their rationale is described .
ROP current understanding and managementFarhadul Alam
Retinopathy of prematurity (ROP) is a vascular disease of the eye unique to preterm infants characterized by failure of retinal blood vessels to grow and develop normally. It results in severe visual impairment and blindness in newborns.
To understand ROP is very important so the newborns can be managed according to the stage efficiently and better visual rehabilitation can be offered to the patients and adequate knowledge can be given to the parents with counseling.
Retinopathy of prematurity is a disease of the developing retina which develops as a result of disruption of the internal milieu of the developing retina leading ultimately to retinal detachment and blindness.
ROP current understanding and managementFarhadul Alam
Retinopathy of prematurity (ROP) is a vascular disease of the eye unique to preterm infants characterized by failure of retinal blood vessels to grow and develop normally. It results in severe visual impairment and blindness in newborns.
To understand ROP is very important so the newborns can be managed according to the stage efficiently and better visual rehabilitation can be offered to the patients and adequate knowledge can be given to the parents with counseling.
Retinopathy of prematurity is a disease of the developing retina which develops as a result of disruption of the internal milieu of the developing retina leading ultimately to retinal detachment and blindness.
The normal twin, called the pump twin, drives blood through both fetuses. It is called reversed arterial perfusion because in the acardiac twin the blood flows in a reversed direction. TRAP sequence occurs in 1% of monochorionic twin pregnancies and in 1 in 35,000 pregnancies overall.
Retinopathy of prematurity (ROP), initially described as retrolental fibroplasia one of the leading cause of blindness in children.
Despite advances in diagnosis and treatment, as medicine and technology advances and premature infants are surviving at earlier gestational ages, ROP continues to be a significant problem.
ROP results in disorganized growth of retinal blood vessels, which may lead to scarring and retinal detachment.
Transcatheter closure of patent ductus arteriosus (PDA) is feasible in low-birth-weight infants. A female baby was born prematurely with a birth weight of 924 g. She had a PDA measuring 3.7 mm. She was dependent on positive pressure ventilation for congestive heart failure in addition to the heart failure medications. She could not be discharged from the hospital even after 79 days of birth, and even though her weight reached 1.9 kg in the neonatal intensive care unit. We attempted to plug the PDA using an Amplatzer Piccolo Occluder, but the device failed to anchor. Then, the PDA was plugged using a 4-6 Amplatzer Duct Occluder using a 6-Fr sheath which was challenging.
Crouzon syndrome is the most common syndrome in the craniosynostosis group. Crouzon syndrome accounts for about 4.8 of all cases. It usually has autosomal dominant inheritance with full penetrance and variable expressiveness from subtle to severe forms and is caused by maxillary hypoplasia with craniosynostosis, proptosis, and relative mandibular protrusion. be characterized. Mutations in the fibroblast growth factor receptor 2 gene have been implicated in the development of this rare genetic disorder. Our work reports the diagnosis of this rare syndrome in young patients based on clinical and radiological features. Prompt and timely treatment of the syndrome has allowed this patient to lead a normal life despite the syndrome. Dr. Kala Barathi. S | Mr. Azrudheen. B "Crouzon Syndrome: A Case Report" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-7 | Issue-1 , February 2023, URL: https://www.ijtsrd.com/papers/ijtsrd53851.pdf Paper URL: https://www.ijtsrd.com/medicine/nursing/53851/crouzon-syndrome-a-case-report/dr-kala-barathi-s
MANDIBULOFACIAL DYSOSTOSIS GUION-ALMEIDA TYPE: A SYNDROME TO RECOGNIZE IN PRE...komalicarol
Mandibulofacial dysostosis with microcephaly, Guion-Almeida
type (MFDGA) is a rare multiple congenital anomalies syndrome
characterized by malar and mandibular hypoplasia, microcephaly,
ear malformations with associated conductive hearing loss, esophageal atresia, cleft palate and distinctive facial dysmorphism. Almost all affected individuals have developmental delay and intellectual disability. To date, more than 100 cases have been described
in the literature. MFDGA is caused by heterozygous variants in the
EFTUD2 gene. Considering the risk of a poor neurodevelopmental
prognosis and the possibility of prenatal genetic diagnosis, MFDGA should be prenatally evocated.
DR VIVEK WANI TALK ON DIABETIC RETINOPATHY FOR KLE MBBS STUDENTS UG KAHER.pptxvbwani
this talk is for MBBS STUDENTS
It gives a summary of diabetic retinopahty including epidemiology, signs and symptoms, pathogenesis , diagnosis, investigations and treatment .
it is fairly brief lecture to make UGs aware of the entity of DR
with lot of images it is a good teaching presentation.
The normal twin, called the pump twin, drives blood through both fetuses. It is called reversed arterial perfusion because in the acardiac twin the blood flows in a reversed direction. TRAP sequence occurs in 1% of monochorionic twin pregnancies and in 1 in 35,000 pregnancies overall.
Retinopathy of prematurity (ROP), initially described as retrolental fibroplasia one of the leading cause of blindness in children.
Despite advances in diagnosis and treatment, as medicine and technology advances and premature infants are surviving at earlier gestational ages, ROP continues to be a significant problem.
ROP results in disorganized growth of retinal blood vessels, which may lead to scarring and retinal detachment.
Transcatheter closure of patent ductus arteriosus (PDA) is feasible in low-birth-weight infants. A female baby was born prematurely with a birth weight of 924 g. She had a PDA measuring 3.7 mm. She was dependent on positive pressure ventilation for congestive heart failure in addition to the heart failure medications. She could not be discharged from the hospital even after 79 days of birth, and even though her weight reached 1.9 kg in the neonatal intensive care unit. We attempted to plug the PDA using an Amplatzer Piccolo Occluder, but the device failed to anchor. Then, the PDA was plugged using a 4-6 Amplatzer Duct Occluder using a 6-Fr sheath which was challenging.
Crouzon syndrome is the most common syndrome in the craniosynostosis group. Crouzon syndrome accounts for about 4.8 of all cases. It usually has autosomal dominant inheritance with full penetrance and variable expressiveness from subtle to severe forms and is caused by maxillary hypoplasia with craniosynostosis, proptosis, and relative mandibular protrusion. be characterized. Mutations in the fibroblast growth factor receptor 2 gene have been implicated in the development of this rare genetic disorder. Our work reports the diagnosis of this rare syndrome in young patients based on clinical and radiological features. Prompt and timely treatment of the syndrome has allowed this patient to lead a normal life despite the syndrome. Dr. Kala Barathi. S | Mr. Azrudheen. B "Crouzon Syndrome: A Case Report" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-7 | Issue-1 , February 2023, URL: https://www.ijtsrd.com/papers/ijtsrd53851.pdf Paper URL: https://www.ijtsrd.com/medicine/nursing/53851/crouzon-syndrome-a-case-report/dr-kala-barathi-s
MANDIBULOFACIAL DYSOSTOSIS GUION-ALMEIDA TYPE: A SYNDROME TO RECOGNIZE IN PRE...komalicarol
Mandibulofacial dysostosis with microcephaly, Guion-Almeida
type (MFDGA) is a rare multiple congenital anomalies syndrome
characterized by malar and mandibular hypoplasia, microcephaly,
ear malformations with associated conductive hearing loss, esophageal atresia, cleft palate and distinctive facial dysmorphism. Almost all affected individuals have developmental delay and intellectual disability. To date, more than 100 cases have been described
in the literature. MFDGA is caused by heterozygous variants in the
EFTUD2 gene. Considering the risk of a poor neurodevelopmental
prognosis and the possibility of prenatal genetic diagnosis, MFDGA should be prenatally evocated.
DR VIVEK WANI TALK ON DIABETIC RETINOPATHY FOR KLE MBBS STUDENTS UG KAHER.pptxvbwani
this talk is for MBBS STUDENTS
It gives a summary of diabetic retinopahty including epidemiology, signs and symptoms, pathogenesis , diagnosis, investigations and treatment .
it is fairly brief lecture to make UGs aware of the entity of DR
with lot of images it is a good teaching presentation.
DR WANI'S TALK ON AMD FOR RESIDENTS 30 March 2020.pptxvbwani
This contains a detailed talk on AMD given in 2020 So slightly old But basic facts remain same It deals with epedemilogy, pathogenesis, risk factors, clincial features, investigations, treatment studies on treatment etc
DR WANI'S TALK ON RETINAL DETACHMENT LECTURE FOR RESIDENTS [DR WANI TALK.pptxvbwani
Dr Wani talks on RD for residents in KLE hospital
This is a detailed talk that deals with all aspects fo RH RD
This talk aims to clear the concepts about RD
It deals the incidence of RH Rd, pathogenesis, cliinical features , diagnosis , treatment options prognosis etc
DR WANI'S TALK ON CRVO FOR RESIDENTS KLE 14 JAN 2023.pptxvbwani
This detailed talk about central retinal vein occlusion deals with all aspects of the disease
It deals with incidence and prevalence, risk factors and clinical features
It also deals with classification, importance of recognizing the ischemic type and the means to recognize it .
It deals with historical studies that gave nformation abour natural course and treatment options
sEveral studies that were conducted to treat CRVO are dealt with in which emphasis is given to anti VEGF drugs
DR WANI'S TALK ON Diabetic Retinopathy Part II december 31 2022 for KLE RES...vbwani
This part iI of DR deals with DME, investigations, treatment options and prognosis in detail
DME also deals with treatment protocols and regimen.
This along with part I is meant for those who want to have in depth knowledge about DR
DR WANI'S TALK ON DIABETIC RETINOPATHY PART I FOR KLE RESIDENTS.pptxvbwani
part I of detailed talk on diabetic retinopathy
covers epidemilogy , risk factors pathogenesis , classification, clinical features in detail
The presentation has lot of pictures
The presentation is based on studies published regaring each topic
It deatls with each clinical sign in detail
It also deals with risk factors for DR with examples of studies conducted
DR WANI'S TALK ON Fundus fluorescein angiography PART II for post graduates.pptvbwani
This presentation talks about abnormal fluorescein angiograph
The causes of hypo flourescence and hyper fluorescence are dealth with in this presentation.
Each condition is illustrated with appropriate images of the FFA.
DR WANI'S TALK ON Fundus fluorescein angiography for post graduates .pptxvbwani
This presentation tells about the principles of FFA, properties of fluorescein, side effects of fluorescein, technique of FFA, the anatomy behind the appearance of FFA in normal eyes
The normal FFA depends upon the retinal barriers and pigmentationin RPE which is highlighted in this talk
DR WANI'S TALK ON Optical coherence tomography of posterior segment FOR KLE ...vbwani
This presentation gives info about 1) History of OCT
2)basics of OCT
3) how it differs from USB scan
4) generations of OCT
5)how the posterior segment OCT is captured
6)normal retina and its layers on the OCT,
7) what abnormalities to look for OCT
8) common retinal diseases and their OCT appearance
DR WANI'S TALK ON Retina anatomy for PGs 2022.pptxvbwani
This is a detailed power point presentation about anatomy of Retina for post graduate students.
Deals with anatomy, structure, cell types, organization of retinal cells, structure of macula, blood supply of retina, number of rods and cones etc
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
3. OBJECTIVES OF THIS TALK
Give an overview of ROP
Highlight the role of neonatologists
in management of ROP
Which babies are for ROP screening
How to arrange ROP screening
How to manage discharged babies
Medico-legal aspects of ROP
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 3
4. Subheadings of the talk
Overview of ROP
Introduction
Definition of ROP
History and epidemiology
Pathogenesis
ROP clinical features and classification
Risk factors for ROP
Treatment guidelines and results
Role -of neonatologists
Screening protocol
Whom, when, how, follow ups and medico-legal aspects
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 4
6. Good reasons are
By knowing about ROP- you refer at risk babies to
ophthalmologists in time and prevent blindness
Blindness in babies is for life
That is a noble service!
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 6
7. Prompt reference, proper screening and laser treatment
done in BE 20 years ago -Now a graduate in US
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 7
8. Bad reasons to know about ROP
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 8
BE AWARE OF ALL PROTOCOLS AND
DO YOUR PART IN CARE OF ROP TO
AVOID SUCH MEDICOLEGAL cases
9. Definition of ROP?
ROP is a vaso-
proliferative
disorder of the
retina in
premature babies
with immature
retina - avascular
area
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 9
10. History of ROP
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 10
Terry 1942 -- two cases of white membranes behind the lenses in
premature babies and termed it as Retrolental Fibroplasia
(RLF)1
Campbell and Patz showed that premature babies receiving
higher oxygen supplementation developed RLF2,3
,
1.Terry TL. Am J Ophthalmol 1942;25:203-204
2. Campbell K. Med J Aust 1951;2:48–50
3. Patz et al Am J Ophthalmol 1952;35:1248–52
11. Knee jerk reaction-curtail oxygen
Reducing oxygen led to reduction in RLF from 50% to
4%4
BUT- a very high rate of mortality and morbidity due
to cerebral palsy 5
It was estimated that by reducing oxygen-for every
baby they saved the sight- there were 16 babies who
either died or had cerebral palsy6
So oxygen was restarted to be used
4. Hatfield EM. Sight Sav Rev 1972;42:69–89
5.. Avery ME, Oppenheimer EH. J Pediatr 1960;57:553–9.
6. Cross KW. Cost of preventing retrolental fibroplasia? Lancet. 1973;2:954–6
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 11
12. Three Epidemics of ROP
First epidemic of RLF or ROP was in 1940s-
50s –soon after oxygen was introduced for
premature babies- none knew about ROP
Second epidemic started in 70s-80s
Due to liberal use of oxygen to prevent
cerebral palsy or death7
Due to increased survival of smaller babies8
7.Gibson DL et al Pediatrics 1989;83:486–92.
8.Valentine PH et al. Pediatrics 1989;84:442–5
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 12
13. The third epidemic -1990s onwards
Advances and expansion of neonatal services in
middle income countries like India, China, Mexico,
Brazil etc are occurring
More premature babies are surviving
So ROP is increasing in these countries -3RD WAVE
It is still going on
It is our duty to expand ROP services to cover every
neonate
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 13
14. How big is ROP problem?
13 million premature babies born every year in the world
And severe ROP in more than 50 000 babies every year9
One in 820 babies born premature may become blind due to
ROP10
An estimated 32000 children went blind world wide in 2010
and 10% of them were in India11
ROP is an important cause of blindness during childhood12
9. Blencowe H et al. Pediatr Res. 2013;74(Suppl 1):35-49
10. Lad et al Br J Ophthalmol 2008;92:320-325
11. Blencowe H et al Indiann Paediattrics 2016;53:supl 2
12. Steinkuller PG et al J AAPOS 1999;3:26 –32.
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 14
15. How does fetal retinal vasculature develop?
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 15
• At 12 weeks of gestation
mesenchymal cells grow out
from the disc
• They form capillaries, venules
and arterioles and then major
vessels
• The avascular retina produce
a cytokine vascular
endothelial growth factor –
VEGF-which promotes
vascularization of retina
• Vessels reach nasal periphery-
ora serrata- at 32 weeks of
gestation and temporal
periphery at term
• So by term, the retina is
fully vascularized LEFT EYE
16. So if a baby is born premature
Some avascular retina will be
present -extent depends upon
prematurity
In such babies
retinal vessels may grow
towards the ora to complete
vascularization of retina in a
normal fashion or
ROP may develop in some
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 16
17. Pathogenesis
Pathogenesis of ROP occurs in two phases13-15
Hyperoxic phase
Hypoxic phase
13. Chen J, Smith LE. Angiogenesis. 2007;10:133-140.
14. Hartnett ME. Ophthalmology. 2015;122:200-210.
15. Mintz-Hitner HA et al N Engl J Med. 2011;364:603-615
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 17
18. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 18
In utero baby lives in hypoxic environment -PaO2 of < 30 mm of Hg.
Hypoxia promotes normal VEGF expression which facilitates
vascularization of retina
If a baby is born premature it is exposed to higher PaO2 of 100 mm
of Hg in room air. Baby may also receive O2 treatment
High PaO2 –no hypoxia - VEGF expression suppressed –needed for
normal growth of blood vessels -so vessel growth stops –vaso-cessation
high PaO2 in blood -O2 radicals –death of endothelial cells of
growing retinal vessels –cause obliteration –vaso-obliteration
Vessels and capillaries stop growing to periphery
The peripheral retina remains avascular - becomes hypoxic -
hypoxia triggers next phase of pathogenesis-HYPOXIC PHASE
HYPEROXIC PHASE 22 to 30 weeks of PMA
19. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 19
Phase 2 –HYPOXIC PHASE-31 to 44 weeks of PCA
Hypoxia causes up-regulation of VEGF and other
growth factors in retinal cells in avascular retina
High VEGF and other growth factors lead to
active ROP and abnormal vaso-proliferation
ROP develops at the junction between
vascularized and avascular retina
These cells now produce VEGF, EPO and IGF1
VEGF levels increase -130 times normal values
20. .
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 20
16. Invest. Ophthalmol. Vis. Sci.. 2008;49(12):5177-5182
21. Classification of ROP
International classification of ROP(ICROP) 17 issued
guidelines to uniformly describe ROP in 1984
Further modifications for this have occurred
subsequently but basic aspects remain same
17. ICROP GROUP Arch Ophthalmol 1984;102:1130-1134
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 21
22. ROP – ICROP17
1) Location
2) Staging
3) Extent
4) Plus disease
17. ICROP GROUP Arch Ophthalmol 1984;102:1130-1134
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 22
23. 1) Location –Zone-
tells us where the disease is located
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 23
26. 2) Stages of ROP
Stage 1-demarcation line
A simple flat line is seen at the edge of advancing vessels
separating avascular from vascular retina
Stage 2-Ridge
The demarcation line becomes thick and has volume
and height –then it is called as ridge-stage 2
It is pinkish or whitish
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 26
28. Stage 3
When new blood vessels called as extra-retinal
proliferations (ERP) develop in addition to the ridge
New vessels may grow
into vitreous or
back on the surface of vascularized retina from the
ridge area giving it ragged appearance
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 28
31. Do all babies who develop stage 1
or 2 progress to stage 3 ROP?
No
Many babies who develop stage 1 or 2 show
spontaneous resolution of disease
Retina may become fully vascularized
Some cases of Stage 3 also show regression
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 31
32. We should not see this stage
Stage 4-subtotal retinal detachment
When extensive ERP
contract they pull
retina TRD
Stage 4a
Macula not involved
Stage 4b
Macula is involved
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 32
33. Stage 5- we should never see it
Total retinal
detachment
Results of surgery
very poor
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 33
34. 3) ICROP- Extent of the disease
We note how many clock
hours of disease is
present
Report as so many clock
hours of the disease
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 34
35. 4) ICROP- 4th component is plus disease MOST
IMPORTANT SIGN
Dilatation and tortuosity of the posterior vessels in
zone 1
Vitreous haze
Pupil rigidity-does not dilate well
Iris vessel engorgement, iris new vessels
PLUS disease is a very important sign and its presence
is usually an indication for treatment
Further classified as pre-plus or plus
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 35
39. ZONE I stage 3 plus disease
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 39
40. When do we treat ROP
The purpose of screening is to catch ROP at treatable
stage and prevent stages 4 and 5
The window of opportunity is small in ROP
One missed appointment -baby may progress from stage 2
to stage 4 or stage 5
So screening a timely protocol is very important
RCTs have established guidelines for treatment
We follow ETROP study guidelines for indications of
treatment 18
18. Early Treatment of Retinopathy of Prematurity Group. Arch Ophthalmol. 2003;121:1684-1694
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 40
41. Type1 ROP (treatment is required)18
Zone I-stage 1 OR 2 ROP with plus disease
Zone I-stage 3 ROPeven without plus disease
Zone II-stage 2 or 3 withplus disease
Treatment is
Retinal ablation of all the avascular retina by laser is
established form of treatment
However presently zone I ROP is treated by
intravitreal injection of anti VEGF
18.Early Treatment of Retinopathy of Prematurity Group. Arch Ophthalmol. 2003;121:1684-1694
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 41
43. ROP that does not meet the criteria of type 1 ROP is
termed as Type 2 ROP
Zone I, stage 1 or 2 ROP without plus disease
Zone II, stage 2 or stage3 ROP without plus disease
No treatment is required at that point of time
But continued follow up is needed
If progresses to type I treat the baby
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 43
44. Aggressive ROP-AROP or APROP
It is fulminant variant of ROP
Seen usually in very small babies
ROP is in the zone 1 or posterior zone 2
Rapidly progresses to higher stages without starting
with stage 1 or 2
Has disproportionate plus disease
Neovascularization of retina may be intraretinal
Treatment results are less satisfactory
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 44
45. ZONE I DISEASE - APROP
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 45
46. How do we treat
A) Laser –laser burns applied to all the avascular
retina which is hypoxic -is producing VEGF. Once is
‘destroyed’ VEGF comes down and
The ROP regresses
B) Anti VEGF injections–in eyes with zone I disease
or aggressive ROP(A-ROP)
Anti VEGF – it neutralizes high levels of VEGF in the
eye and stops neovascularization
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 46
51. What are the risk factors for ROP
Lower Gestational age at birth-prematurity
Lower Birth weight-prematurity
Oxygen administration
Need for ventilation
HMD
CLD
Sepsis
Intra-ventricular hemorrhage
Need for blood transfusion
Poor postnatal weight gain
NEEC
PDA
Many other factors
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 51
52. Oxygen spO2
Keeping SpO2 83% and 93% from birth and during
transport virtually eliminated severe ROP
Need for laser treatment was 4.5% for high SpO2
(90%–98%) versus 0% for low SpO2 (85%–93%)19
19.Chow LC, et al . Pediatrics. 2003;111:339–45.
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 52
53. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 53
EVENT HIGHER
OXYGEN
91-95%
LOWER
OXYGEN
85-89%
RR LEVEL
P VALUE
MEANI
NG
PRIMARY
OUTCOME
51.6% 53.5% P=0.21 NS
DEATH 17.1% 19.9% P=0.01 S
ROP treatment
need
14.9% 10.9% P < .001 S
NEEC 6.9% 9.2% P = .003 S
NEOPROM STUDY20
20. Askie LM et al JAMA. 2018 Jun 5;319(21):2190-2201.
54. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 54
21
21. Wani et al Indian J Ophhthlamol 2010;58: 204-208
55. 22. Middle East Afr J Ophthalmol.2013;20(1):66-71.
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 55
56. Incidence of ROP and type I ROP-KLE experience 2019 one year
data
1/6/2023 56
Study and place of
study
Number of
infants
Inclusion criteria
GA* and BW†
Mean BW± SD in grams
GA± SD in weeks
Any ROP%
Type 1 ROP%
Quinn et al 6
USA
7483 GA≤30
BW<1500g
28 ± 3
1099± 259
43.1
6.9
Braimah et al7
Ghana
401 GA<37
BW<2000
32.2± 2.4
1600± 400
13.7
1.8
Bas et al 10
Turkey
6115 GA<32 W
BW <1500G
1457±479
28.9±6.3
27
6.7
Ahuja et al11
India
325 GA≤36 W
BW ≤1900G
1420±300
30.68±2.84
32.6
13.2
Vinekar et al 14
India
4167 GA<34
BW<2000G
1592.7
31.7
24.33
4.4
Castellon et al21
Mexico
132 GA≤34
BW <1700g
1594±96
32±3
56.1
28.8
ETROP study23
USA
6998 BW <1251g 907
27.4
68
36.9
Present study 263 GA<34
BW<2000G
1598.8 ±440.1
33± 2.8
24.3
5.7
57. Results of treatment of ROP till
2021 in KLE
55 babies(KLE BORN AND OUTSIDE BORN)
GA 30.1( 27-33)weeks
BWT 1299.7( 718-2500)g
PCA at treatment 35.9 weeks
AROP in 6 babies
20 treated by anti vegf injections
None developed RD
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 57
58. Role of Pediatricians in ROP
Which premature babies to screen?23
Following guidelines are from Govt. of India
Birth weight(BW) less than or = 2000g
Gestational age(GA) less than or =34 weeks
GA 34-36 weeks n BW >2000G but has following
risk factors
a) Cardiopulmonary support b) Prolonged oxygen administration c)Respiratory
distress syndrome d) Chronic lung disease e)Fetal hemorrhage f)Blood transfusion
g)Neonatal infection h)Exchange transfusion i)Intraventricular hemorrhage j)Apneas
k)Poor postnatal weight gain
Infants with unstable clinical course who are at
high risk (as determined by neonatologist)
23 https://nhm.gov.in/images/pdf/programmes/RBSK/Resource_Documents/Revised_ROP_Guidelines-Web_Optimized.pdf
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 58
59. Who chooses the babies for
screening?
The neonatologist will choose the babies
All the names of eligible babies are entered in a
register by an assigned staff and date for first screening
to be entered in the register
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 59
60. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 60
Rashtriya Bala Swasthya Karykrama
June 201723
61. When to perform the first ROP
screening?23
Early screening for babies born with GA < 28 weeks
OR babies with BW<1200g
-first ROP screening at 2-3 weeks after birth (To detect
AROP)
All other babies undergo the first ROP screening at
four weeks after birth
23. https://nhm.gov.in/images/pdf/programmes/RBSK/Resource_Documents/Revised_ROP_Guidelines-
Web_Optimized.pdf
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 61
62. Sample register entry
Name
of
baby
IP
nu
mbe
r
DOB SE
X
GA
wk
s
BW
g
I ROP
screening
date
Mobile
of
parent
s
b/o
ABC I
twin
32**
****
01/01/2018 M 29 1150 14 or 21 of
January 2018
988****
***
b/o
ABC II
twin
32**
****
01/01/2018 M 29 1240 28TH JAN 2018 same
b/o
MNO
33**
****
25/01/2018 F 30 1400 25/2/2018 944****
***
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 62
63. Baby unfit for eye examination
In case the baby is too sick to tolerate dilatation & ROP
screening is postponed
Neonatologist should
Clearly write in the case sheet the reason for
cancellation of screening examination
ROP screening at the earliest possible to be arranged
Inform the parents
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 63
64. Who performs the screening?
It is an ophthalmologist who is experienced in ROP
examination and management
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 64
65. Arrangement regarding visit of the Ophthalmologist to the
nursery
Neonatology and Ophthalmologist should arrange
day/days to conduct ROP screening examination/s
Usually a fixed day and timings are preferred to avoid
confusion except under special circumstances
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 65
66. Arrangement regarding visit of the Ophthalmologist to the
nursery
The staff of NICU should inform the timing of eye
examination to all the sections of the Neonatology
dept-NICU, WARDS, OPDs
Babies for first time ROP screening and follow up
examinations are to be included (see later)
Keep the pupils dilated of all the selected babies
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 66
67. The method for dilatation of the pupils
1) 0.5% Tropicamide every 15 minutes for three times-0,15,30
minutes
OR
2) Cyclopentolate 0.5% eye drops (Cyclogyl) to be used every 15
minutes for three times 0, 15, 30 minutes
AND
3) At 45 minutes Tropicamide 0.5% with 2.5% phenylephrine
combination is instilled
If the above strengths are not available( TROPICACYL PLUS, I
TROP –need dilution) then commercially available drops should
be diluted with artificial eye drops and required strength of drops
prepared
Difficult to dilate eyes could be harboring severe ROP
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 67
68. The method for dilatation of the pupils
Instill one drop only in the conjunctival sac after
pulling the lower lid
Wipe out the excessive drops that spill out onto the
cheek to prevent systemic absorption through the thin
skin
Monitor BP and HR, decreased bowel movements,
paralytic ileus and other side effects
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 68
69. Systemic effects of dilating drops for
retinopathy of prematurity
Increase in BP, heart rate, renal failure,
acute gastric dilatation, paralytic ileus
have all been reported as side effects of
dilating drops24-26
24.Laws et al Br J Ophthalmol. 1996 ;80(5):425-8
25. Shinomiya K et al J Med Invest. 2003;50:203-6
26. Sarici SU et al Pediatr Radiol. 2001 Aug;31(8):581-3
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 69
70. How to arrange screening
Start dilating the eyes 1 ½ hour before arrival of
ophthalmologist
Information leaflet to be given to parents and a
common consent taken for multiple ROP screenings
ROP examination sheet for each baby should be filled
up and kept ready
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 70
73. Aseptic techniques should be
followed for ROP examination
Washing hands before and between cases
Preferably wear sterile gloves for each baby
Sterile instruments for each baby
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 73
74. What is done after ROP
examination
The findings are entered in the ROP sheet in triplicate
by the examining ophthalmologist
Clear instructions
When is the follow up
Does the child need treatment for ROP or follow up
only?
The babies in Nursery and OPD who are advised
follow up are to be entered in a separate registers for
follow up --date wise
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 74
75. Guidelines for follow up intervals
Follow up intervals depend upon
extent of retinal vascularization
stage of ROP and
presence or absence of pre plus disease
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 75
76. Follow up intervals-
ophthalmologist decides it
1. More posterior the zone more often do we see the
baby
2. No ROP but retinal vessels in zone I still - every week
3. No ROP but retina vessels in zone II- every 2 weeks
4. Zone I ROP stage 1 or 2 with no plus disease –every
week or earlier
5. Zone II ROP stage 1 no plus disease every 2 weeks
6. Zone II ROP stage 2 or 3 no plus --every one week or
earlier if pre plus present
7. Zone III – No ROP every 2-3 weeks
8. Zone III- ROP stage 1-2 no plus every two weeks
9. Zone III-ROP stage 3 no plus every week
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 76
77. Appointments on date 26-3-2018
Name of
baby
File
number
DOB Examine
d
BEFORE
S NO of
exam
FU
advice
Remarks
b/o xyz 43^^^^ 24-01-
2018
No 1 After one
week
b/o mnl 34**** 12-02-
2018
Yes 4th exam After 2
weeks
b/o abc 36**** 10-01-2018 Yes 5th exam After one
mo
Discharged
FU given for
OPD
ophthalm
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 77
78. When should we stop ROP follow
up?
To be decided by ophthalmologist and not you!
Babies are to be followed till
a. Retina is fully vascularized both nasally and
temporally
b. If ROP stages were present they completely regress
and retinal vessels reach temporal ora serrata
c. Usually follow ups are needed up to 45-50 weeks of
PCA
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 78
79. What happens when a baby that needs ROP screening is
discharged home
See the recommendation of Ophthalmologist in the
last ROP screening
Give verbal AND written instructions to the parents
regarding date and place of next ROP screening
The parent’s signature should be taken in a register to
the effect that he/she has been informed about the
need of ROP screening, ITS IMPORTANCE and has
been given a referral letter with date and place of
referral
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 79
80. What happens when a baby that needs ROP screening is referred
or transferred to another hospital for care
The referral letter to that center should clearly
mention the scheduled date of ROP screening and
request that hospital to arrange for an ophthalmologist
for it
Parents should be informed about it and signature
taken
Documentation regarding these is very important to
avoid legal hassles
These referrals are to be given by the
NEONATOLOGIST as they are the ones who discharge
or transfer the patient
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 80
81. FOLLOW UP EXAMINATIONS
after ROP discharge
a. All premature babies with ROP are at high risk of
developing myopia and squint
b. More severe the ROP- greater the degree of myopia
c. ROP treated babies commonly develop high myopia
d. Premature babies even without ROP are at higher
risk of developing myopia AND strabismus
compared to FT babies
e. So these babies need annual examinations even if the
ROP has regressed completely or there was no ROP
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 81
82. 270 eyes of 148 babies
treated by laser
between 1999 to 2003
20 eyes (7.6%)
Unfavorable
structural outcome
47% of eyes had
VA of <20/40
17% eyes had myopia of 5 D or more
Zone I disease
Was the risk factor
For structural,
refractive and
visual
Unfavorable
Outcomes
82
27. Wani et al Clinical Ophthalmology 2013
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI
83. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 83
28. Day et al Arch Ophthalmol 2009;127:794-798
84. Counseling the parents of babies
with Type I ROP-ophthalmologist
Alert the parents of infants who are nearing Type I
status-pediatrician and ophthalmologist
An informed consent for treatment for TYPE I
ROP is must
The ophthalmologist will counsel the parents and
consent taken in the Neonatology
department/OPD
Even with early treatment of eyes with type I ROP,
some eyes may still progress to an unfavorable
visual and/or structural outcome
This is especially true for eyes with Zone I disease
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 84
85. Guidelines for the treatment
Written informed consent from parents
Treatment -in operation theater or NICU
Arrange OT
Start dilate both eyes 1 ½ hour before timing of laser
A neonatologist must accompany the child to the OT and
manage emergencies SOS
IF no contraindication then baby may be given sedation as
appropriate
Both laser treatment and anti VEGF inj are carried out
under topical anesthesia with infant being restrained by
staff nurse
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 85
86. POST LASER ROP AFTER 10 YEARS
1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 86
87. 1/6/2023 ROP FOR PEDIATRICIANS BY DR WANI 87
Thanks for your kind attention